On September 7th, LIVZON PHARMA (01513) spent 22,456,300 yuan to repurchase 668,000 A-shares.
LIVZON PHARMA (01513) has announced that on September 7, 2023, the company will spend RMB 22,456,300 to repurchase 668,000 shares of A-shares. The repurchase price per share ranges from 33.5 to 33.82 yuan.
Related Articles
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
The People's Bank of China has increased its gold holdings for the 15th consecutive month.
Guosen: RWA welcomes the era of strict supervision.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
The People's Bank of China has increased its gold holdings for the 15th consecutive month.
Guosen: RWA welcomes the era of strict supervision.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
